Transcriptional Regulation of Brain-Derived Neurotrophic Factor (BDNF) by Methyl CpG Binding Protein 2 (MeCP2): a Novel Mechanism for Re-Myelination and/or Myelin Repair Involved in the Treatment of Multiple Sclerosis (MS)

Title
Transcriptional Regulation of Brain-Derived Neurotrophic Factor (BDNF) by Methyl CpG Binding Protein 2 (MeCP2): a Novel Mechanism for Re-Myelination and/or Myelin Repair Involved in the Treatment of Multiple Sclerosis (MS)
Authors
Keywords
Multiple sclerosis (MS), Epigenetics, Histone deacetylase (HDAC) inhibitors, Experimental autoimmune encephalomyelitis (EAE), Methyl CpG binding protein 2 (MeCP2), Brain-derived neurotrophic factor (BDNF), Autoimmune disease
Journal
MOLECULAR NEUROBIOLOGY
Volume 53, Issue 2, Pages 1092-1107
Publisher
Springer Nature
Online
2015-01-12
DOI
10.1007/s12035-014-9074-1

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More